CNLM Insider Trading Activity and SEC Form 4 Filings
CNLM insider trading summary
No open-market insider purchases or sales of CB Pharma Acquisition Corp. (CNLM) have been reported on SEC Form 4 in the past 12 months.
Latest CNLM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 20, 2016 | Arthur Asher Kornbluth | Director | Sell | $0 (10,000 @ $0.00) |
| May 20, 2016 | Neil Herskowitz | Director | Sell | $0 (10,000 @ $0.00) |
| May 20, 2016 | Lindsay A Md Rosenwald | Co-Chairman and CEO | Sell | $0 (1,020,000 @ $0.00) |
| May 20, 2016 | Fortress Biotech, Inc. | 10% Owner | Sell | $0 (1,020,000 @ $0.00) |
| May 20, 2016 | Adam J. Chill | Director | Sell | $0 (10,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.